We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biomechanical Ratchet Traps Cancer Cells Before They Can Spread

By LabMedica International staff writers
Posted on 29 Jun 2009
Researchers have demonstrated the possibility of using a biomechanical ratchet to sort normal and cancerous cells as a means to trap tumor cells before they spread to other areas of the body. More...


In several important physiologic processes, particularly cancer metastasis, randomly moving cells can acquire a directional motility phenotype and bias their motions in response to environmental cues. Researchers still do not understand why cells migrate in a specific direction.

In the current study, researchers from Northwestern University (Evanston, IL, USA) incorporated molecular cues (cell-adhesive and cell-repellant chemical compounds) into a "microgeometry” substrate that was keyed to the difference in shape between normal epithelial (long and thin with long protrusions on the ends) and cancer (round and broad) cells.

The microscopic ratchets contained channels with "spikes” protruding at 45o angles from the walls, alternating on opposite sides of the channel. This pattern funneled cancer cells in one direction while at the same time directing the normal cells in the opposite direction, as those cells could attach to the spikes and pull themselves through the channel. The cancer cells could be channeled into a closed chamber from which they could not escape.

The feasibility of the system was tested using melanoma, breast cancer, and normal cells, and the results were reported in the June 14, 2009, online edition of the journal Nature Physics.

"We have demonstrated a principle that offers an unconventional way to fight metastasis, a very different approach from other methods, such as chemotherapy,” said senior author Dr. Bartosz Grzybowski, associate professor of chemical and biological engineering at Northwestern University. "These are fundamental studies so the method needs to be optimized, but the idea has promise for a new approach to cancer therapy.”

Related Links:

Northwestern University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.